Literature DB >> 19491273

Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells.

Olivier Meurette1, Spyros Stylianou, Rebecca Rock, Giovanna M Collu, Andrew P Gilmore, Keith Brennan.   

Abstract

The Notch pathway is aberrantly activated in a wide range of cancers, including breast carcinoma, and is required to maintain the transformed phenotype of many of these tumors. Notch signaling contributes to the transformed phenotype, in part, by preventing apoptosis in response to many different stimuli. However, it is unclear how Notch activation can lead to a general suppression of apoptosis. We show here that Notch signaling induced an autocrine signaling loop that activates Akt in breast epithelial cells. This activation of Akt was necessary for Notch-induced protection against apoptosis in the nontransformed breast epithelial cell line MCF10A. Moreover, inhibiting Notch signaling in breast cancer cells induced a decrease in Akt activity and an increase in sensitivity to apoptosis. Finally, the inhibition of ASK1 by Akt was responsible for the protection from apoptosis induced by DNA damage, as it prevented c-Jun NH(2)-terminal kinase-mediated phosphorylation and activation of p53.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19491273     DOI: 10.1158/0008-5472.CAN-08-3478

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  66 in total

Review 1.  Targeting Notch to target cancer stem cells.

Authors:  Antonio Pannuti; Kimberly Foreman; Paola Rizzo; Clodia Osipo; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 2.  Therapeutic approaches to modulating Notch signaling: current challenges and future prospects.

Authors:  Casper Groth; Mark E Fortini
Journal:  Semin Cell Dev Biol       Date:  2012-01-30       Impact factor: 7.727

3.  Evi1 regulates Notch activation to induce zebrafish hematopoietic stem cell emergence.

Authors:  Martina Konantz; Elisa Alghisi; Joëlle S Müller; Anna Lenard; Virginie Esain; Kelli J Carroll; Lothar Kanz; Trista E North; Claudia Lengerke
Journal:  EMBO J       Date:  2016-09-16       Impact factor: 11.598

Review 4.  Notch Signaling in Vascular Smooth Muscle Cells.

Authors:  J T Baeten; B Lilly
Journal:  Adv Pharmacol       Date:  2016-08-26

5.  p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1.

Authors:  Jieun Yun; Ingrid Espinoza; Antonio Pannuti; Damian Romero; Luis Martinez; Mary Caskey; Adina Stanculescu; Maurizio Bocchetta; Paola Rizzo; Vimla Band; Hamid Band; Hwan Mook Kim; Song-Kyu Park; Keon Wook Kang; Maria Laura Avantaggiati; Christian R Gomez; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

6.  HDAC inhibition synergistically enhances alkylator-induced DNA damage responses and apoptosis in multiple myeloma cells.

Authors:  Choon-Kee Lee; Shuiliang Wang; Xiaoping Huang; John Ryder; Bolin Liu
Journal:  Cancer Lett       Date:  2010-05-05       Impact factor: 8.679

7.  Role of the DLL4-NOTCH system in PGF2alpha-induced luteolysis in the pregnant rat.

Authors:  Fatima Hernandez; Marina C Peluffo; Richard L Stouffer; Griselda Irusta; Marta Tesone
Journal:  Biol Reprod       Date:  2011-01-05       Impact factor: 4.285

8.  Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis.

Authors:  Srinivas Koduru; Raj Kumar; Sowmyalakshmi Srinivasan; Mark B Evers; Chendil Damodaran
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

9.  Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer.

Authors:  He Zhu; Feriyl Bhaijee; Nivin Ishaq; Dominique J Pepper; Kandis Backus; Alexandra S Brown; Xinchun Zhou; Lucio Miele
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

10.  Notch versus the proteasome: what is the target of gamma-secretase inhibitor-I?

Authors:  Anthony G Clementz; Clodia Osipo
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.